Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

For each 5 percentage point increase in the U.S. tariff rate, the S&P 500 (SP500) EPS would reduce by 1-2%, said David Kostin, chief U.S. equity strategist at Goldman Sachs, in a note. A sustained 25% ...

In the twisty procedural drama "The Hunting Party," a team of investigators must round up escaped serial killers after a huge ...

Despite a sharp tech sell-off earlier this week sparked by the launch of Chinese startup DeepSeek's AI model, major market ...

Indian equity markets continue to offer an attractive investment opportunity, with the Nifty 50 expected to witness strong ...

Looking ahead to fiscal 2025, Tractor Supply is targeting net sales growth in the mid-single digits, with an EPS range ...

Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...

Dover Corporation reported Q4 results with revenue at $1.930B, up 1% Y/Y but missed consensus. Company expects margin improvement in 2025 with double-digit EPS growth.

Reports Q4 revenue $3.7B, consensus $3.97B. Tim Knavish, PPG (PPG) chairman and chief executive officer, commented on the year and quarter: ...

Reports Q3 revenue $1.83B, consensus $1.73B. “Deckers posted exceptional results in the third quarter, delivering record quarterly revenue, ...

Comerica Inc (NYSE:CMA) shares are trading lower in premarket Wednesday after the fourth-quarter FY24 earnings result. The ...

Revenue only grew 2 percent year over year for Tesla in Q4 2024.